KRAS and pancreatic neoplasm: Another research also reports that non-autologous exosomes can deliver CRISPR/Cas9 plasmid DNA which targets the mutant Kras G12D into recipient pancreatic cancer cells in syngeneic subcutaneous and orthotopic models and suppresses proliferation and tumor growth in these models 42.